Skip to main content
. 2018 Jun 22;6(3):184–188. doi: 10.1093/gastro/goy014

Table 2.

Comparison of modified Pouchitis Disease Activity Index (mPDAI) symptom and endoscopy subscores pre and post treatment with vedolizumab

Pre treatment Post treatment P-value
mPDAI symptom subscore 5.08 ± 0.79 3.50 ± 1.93 0.015
mPDAI endoscopy subscore in the afferent limb 1.25 ± 1.36 0.91 ± 1.50 0.583
mPDAI endoscopy subscore in the pouch body 2.58 ± 1.68 2.27 ± 2.05 0.701
mPDAI endoscopy subscore in the cuff 2.67 ± 1.93 2.09 ± 2.12 0.511